Nevadans sue drug companies for causing 'compulsive gambling' problem
March 9 (UPI) -- Five Nevadans filed a lawsuit this week against the makers of Abilify, an anti-psychotic drug, they say caused them to develop a gambling problem.
The plaintiffs argue that Japanese drug developer Otsuka Pharmaceutical Co. Ltd. its American branch, Otsuka America Pharmaceutical Inc. and marketing partner Bristol-Myers Squibb did not add a warning of potential side effects on Abilify's label that included compulsive gambling in the United States before 2016 "despite opportunities and a duty to do so," the Las Vegas Review-Journal reported.
But the companies had knowledge of the potential side effect since it included a "pathological gambling" warning to the drug's label in Canada and Europe.
The plaintiffs said they never had problems with gambling before they started taking Abilify and they ended up suffering "anxiety, stresses, and in some cases the loss of homes, the loss of credit."
Read more: https://www.upi.com/Top_News/US/2018/03/09/Nevadans-sue-drug-companies-for-causing-compulsive-gambling-problem/5211520577065/